These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


632 related items for PubMed ID: 28734065

  • 1. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, Kesper K, Adriaanse SM, Booij J, Leenders KL, Oertel WH.
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [Abstract] [Full Text] [Related]

  • 2. The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease.
    Meles SK, Renken RJ, Janzen A, Vadasz D, Pagani M, Arnaldi D, Morbelli S, Nobili F, Mayer G, Leenders KL, Oertel WH, REMPET Study Group.
    J Nucl Med; 2018 Sep; 59(9):1437-1444. PubMed ID: 29476004
    [Abstract] [Full Text] [Related]

  • 3. Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
    Janzen A, Vadasz D, Booij J, Luster M, Librizzi D, Henrich MT, Timmermann L, Habibi M, Sittig E, Mayer G, Geibl F, Oertel W.
    J Parkinsons Dis; 2022 Sep; 12(6):1921-1935. PubMed ID: 35754288
    [Abstract] [Full Text] [Related]

  • 4. Four-Year Follow-up of [18 F]Fluorodeoxyglucose Positron Emission Tomography-Based Parkinson's Disease-Related Pattern Expression in 20 Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal Progression.
    Kogan RV, Janzen A, Meles SK, Sittig E, Renken RJ, Gurvits V, Mayer G, Leenders KL, Oertel WH, REMPET Working Group.
    Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
    [Abstract] [Full Text] [Related]

  • 5. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
    Iranzo A, Santamaría J, Valldeoriola F, Serradell M, Salamero M, Gaig C, Niñerola-Baizán A, Sánchez-Valle R, Lladó A, De Marzi R, Stefani A, Seppi K, Pavia J, Högl B, Poewe W, Tolosa E, Lomeña F.
    Ann Neurol; 2017 Sep; 82(3):419-428. PubMed ID: 28833467
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.
    Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.
    Mov Disord; 2018 Mar; 33(3):478-482. PubMed ID: 29380907
    [Abstract] [Full Text] [Related]

  • 9. Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern-case reports.
    Oertel WH, Janzen A, Henrich MT, Geibl FF, Sittig E, Meles SK, Carli G, Leenders K, Booij J, Surmeier DJ, Timmermann L, Strupp M.
    Nat Commun; 2024 Sep 02; 15(1):7619. PubMed ID: 39223119
    [Abstract] [Full Text] [Related]

  • 10. Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.
    Janzen A, Kogan RV, Meles SK, Sittig E, Renken RJ, Geibl FF, Booij J, Stormezand G, Luster M, Mayer G, Leenders KL, Oertel WH.
    Mov Disord; 2022 Mar 02; 37(3):624-629. PubMed ID: 34796976
    [Abstract] [Full Text] [Related]

  • 11. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A, Lomeña F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, Molinuevo JL, Serradell M, Duch J, Pavía J, Gallego J, Seppi K, Högl B, Tolosa E, Poewe W, Santamaria J, Sleep Innsbruck Barcelona (SINBAR) group.
    Lancet Neurol; 2010 Nov 02; 9(11):1070-7. PubMed ID: 20846908
    [Abstract] [Full Text] [Related]

  • 12. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
    Arnaldi D, Chincarini A, Hu MT, Sonka K, Boeve B, Miyamoto T, Puligheddu M, De Cock VC, Terzaghi M, Plazzi G, Tachibana N, Morbelli S, Rolinski M, Dusek P, Lowe V, Miyamoto M, Figorilli M, Verbizier D, Bossert I, Antelmi E, Meli R, Barber TR, Trnka J, Miyagawa T, Serra A, Pizza F, Bauckneht M, Bradley KM, Zogala D, McGowan DR, Jordan L, Manni R, Nobili F.
    Brain; 2021 Feb 12; 144(1):278-287. PubMed ID: 33348363
    [Abstract] [Full Text] [Related]

  • 13. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
    Fujishiro H, Iseki E, Murayama N, Yamamoto R, Higashi S, Kasanuki K, Suzuki M, Arai H, Sato K.
    Psychogeriatrics; 2010 Sep 12; 10(3):144-52. PubMed ID: 20860570
    [Abstract] [Full Text] [Related]

  • 14. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH.
    Acta Neuropathol; 2017 Apr 12; 133(4):535-545. PubMed ID: 28180961
    [Abstract] [Full Text] [Related]

  • 15. Reduced dopamine transporter binding predicts early transition to Lewy body disease in Japanese patients with idiopathic rapid eye movement sleep behavior disorder.
    Miyamoto T, Miyamoto M, Numahata K, Onoue H, Akaiwa Y, Sairenchi T.
    J Neurol Sci; 2020 Jul 15; 414():116821. PubMed ID: 32330698
    [Abstract] [Full Text] [Related]

  • 16. Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder.
    Huang Z, Jiang C, Li L, Xu Q, Ge J, Li M, Guan Y, Wu J, Wang J, Zuo C, Yu H, Wu P.
    J Cereb Blood Flow Metab; 2020 Mar 15; 40(3):552-562. PubMed ID: 30741074
    [Abstract] [Full Text] [Related]

  • 17. [Striatal dopamine transporter levels in patients with REM sleep behavior disorder: assessment with 123I-FP-CIT SPECT].
    Mossa EP, Niccoli Asabella A, Iuele F, Stabile Ianora AA, Giganti M, Rubini G.
    Recenti Prog Med; 2012 Nov 15; 103(11):500-4. PubMed ID: 23096739
    [Abstract] [Full Text] [Related]

  • 18. Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder.
    Shin JH, Lee JY, Kim YK, Yoon EJ, Kim H, Nam H, Jeon B.
    Neurology; 2021 Jul 27; 97(4):e378-e388. PubMed ID: 34011571
    [Abstract] [Full Text] [Related]

  • 19. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.
    Zoetmulder M, Nikolic M, Biernat H, Korbo L, Friberg L, Jennum P.
    J Clin Sleep Med; 2016 Jun 15; 12(6):895-903. PubMed ID: 27070245
    [Abstract] [Full Text] [Related]

  • 20. Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease.
    Arnaldi D, Meles SK, Giuliani A, Morbelli S, Renken RJ, Janzen A, Mayer G, Jonsson C, Oertel WH, Nobili F, Leenders KL, Pagani M, REMPET Study Group.
    J Parkinsons Dis; 2019 Jun 15; 9(1):229-239. PubMed ID: 30741687
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.